Skip to main content
MET
NYSE Finance

MetLife Reports Strong Q1 2026 Earnings with Increased Net Income and EPS, Alongside Significant Capital Actions

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Positive
Importance info
8
Price
$78.6
Mkt Cap
$51.395B
52W Low
$67.33
52W High
$83.85
52W Position info
17% above low
Off High info
6.3% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

MET sits 17% above its 52-week low of $67.33.

Summary

MetLife reported strong Q1 2026 financial results with increased net income and EPS, supported by a $1.0 billion subordinated debt issuance and $755 million in share repurchases.


Key Events · Earnings and Guidance · MET

  • Increased Net Income and EPS

    Net income available to common shareholders rose to $1,140 million in Q1 2026 from $879 million in Q1 2025, with basic EPS increasing to $1.75 from $1.29.

  • Subordinated Debt Issuance

    The company issued $1.0 billion of 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due March 2056 in February 2026.

  • Significant Share Repurchases

    MetLife repurchased 10,121,118 shares of its common stock for $755 million during Q1 2026, with $1.317 billion remaining under existing authorizations.

  • Improved Effective Tax Rate

    The effective tax rate on income before provision for income tax decreased to 23% in Q1 2026 from 30% in Q1 2025.


Analysis · MET · Finance

MetLife's Q1 2026 10-Q filing confirms robust financial performance, building on the positive adjusted EPS reported in the recent 8-K. The company demonstrated substantial year-over-year growth in GAAP net income and basic EPS, indicating strong operational results. Concurrently, MetLife actively managed its capital structure by issuing $1.0 billion in subordinated debt and executing $755 million in common stock repurchases, reflecting a balanced approach to financing and shareholder returns. The improved effective tax rate further contributed to the favorable earnings, reinforcing a positive outlook for the company's financial health.

How filings like this one have moved

In the 30 days to Oct 6, 2026, 36.5% of the 1012 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MET was trading at $78.60 on NYSE in the Finance sector, with a market capitalization of approximately $51.4B. The 52-week trading range was $67.33 to $83.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MET - Latest Insights

MET
Sep 24, 2026, 4:13 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $97.25
Real-time Price: $97.57 info
Change: +$0.320 (+0.33%) info
Market Cap: $62.003B info
MET
Aug 05, 2026, 4:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $97.00
Real-time Price: $97.57 info
Change: +$0.570 (+0.59%) info
Market Cap: $62.003B info
MET
Aug 05, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $96.26
Real-time Price: $97.57 info
Change: +$1.31 (+1%) info
Market Cap: $62.003B info
MET
Jun 29, 2026, 6:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $85.38
Real-time Price: $97.57 info
Change: +$12.19 (+14%) info
Market Cap: $62.003B info
MET
Jun 29, 2026, 6:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $85.38
Real-time Price: $97.57 info
Change: +$12.19 (+14%) info
Market Cap: $62.003B info